Thanks Girish Harinath for the heads up on these studies
The authors reported that in obese mice, daily AOD-9604 administration over 14 days produced significant reductions in body weight gain, decreases in adipose tissue mass, and increases in fat oxidation, with effect sizes comparable to those of full-length human growth hormone [1]
Patients gain a clear understanding of how injections fit into a comprehensive, medically supervised weight loss plan
Subsequently, the levels of glutathione (GSH), superoxide dismutase (SOD), glutathione peroxidase (GPx), malondialdehyde (MDA), and catalase (CAT) were quantified
These additional metrics can show progress even when the scale seems stuck, especially during the natural plateaus that often occur with GLP-1 therapy
DOI: 10.1155/2012/736161